Managing schizophrenia presents numerous challenges, including the need to address various symptom domains. This presentation will explore ongoing research and data-driven trends in adjunctive treatment approaches and examine the underlying pathophysiology across neurotransmitter systems that may contribute to the symptoms of schizophrenia.
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Faculty Information
View biographical information
Austin Campbell, PharmD, BCPP, FAAPP
Clinical Associate Professor
UMKC School of Pharmacy at MU
Adjunct Assistant Professor
MU School of Medicine
Columbia, Missouri
Learning Objectives
- Review classical understanding of schizophrenia pathophysiology.
- Explore ongoing research and data-driven trends in adjunctive treatment approaches​.
- Examine the underlying pathophysiology across neurotransmitter systems that may contribute to the symptoms of schizophrenia.
Continuing Education Credit and Disclosures
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.